Thomas Gray Patient Story
☑ Quick summary
Four years after losing his wife to small cell lung cancer, Thomas Gray was diagnosed with the same disease. He became the first patient at his FCS clinic to join a clinical trial, and his cancer has stopped spreading.

✦ Did you know?
According to the American Cancer Society, about two in three people diagnosed with small cell lung cancer already have extensive-stage disease at the time of their diagnosis because it grows and spreads very quickly.
I look at it in a positive way—if it helps me, maybe the next person will get more time.
✦ Key highlights
- • Diagnosed with extensive small cell lung cancer in August 2025 after emergency brain surgery
- • First patient at his clinic to enroll in a trial of an investigational targeted therapy
- • Cancer is no longer spreading, and his lung tumor has shrunk
- • Cared for by Raju Vaddepally, MD, and Joel Grossman, MD, in Naples
- • Uses humor to lift other patients’ spirits during clinic visits
Finding Happiness In Every Day While Advancing Lung Cancer Research
Thomas Gray’s positive outlook inspires his commitment to clinical trial participation to help uncover future treatment options.
Thomas Gray’s wife, Lori, passed away in 2021, less than two years after being diagnosed with extensive small cell lung cancer—an aggressive disease that had spread beyond her lungs.
Despite losing his beloved partner after 19 years of marriage, Thomas maintained his naturally positive outlook about living. He recalls, “I kept saying my prayers at night and thinking, ‘I still get to spend time with my kids’ (the couple has a son and four daughters) and ten grandbabies.”
Thomas continued working as a glass cutter and shop manager. In August 2025 he woke feeling ill, went to the ER and was discharged. He returned the next day, feeling 100 times worse and struggling to walk, and was immediately transferred to the University of Miami for emergency surgery to remove a tumor that was found in his brain.
The surgeons confirmed the tumor was cancerous and had spread from his lungs. Thomas had extensive small cell lung cancer—the same disease that had taken his wife’s life.
With little time to absorb the news, everything moved quickly from diagnosis to treatment.
He returned home to Naples and began follow-up care with Florida Cancer Specialists & Research Institute (FCS) medical oncologist and hematologist Raju Vaddepally, MD. He soon learned he was eligible for a clinical trial to evaluate an investigational targeted therapy that may offer a new option for patients whose small cell lung cancer has advanced despite standard therapies.
Thomas was the first at the clinic to enroll. While there were times during his illness when he admits to being “scared to death,” he had no hesitation about starting in the clinical trial, overseen by FCS medical oncologist and hematologist Joel Grossman, MD.
“The only way you’re ever going to find a cure for this is if people keep trying,” he said. “I look at it in a positive way—if it helps me, maybe the next person will get more time. And maybe it actually becomes that no one has to go through this stuff at all.”
Dr. Vaddepally notes that Thomas views participation in research as an opportunity to leave something meaningful behind. He said, “Thomas believes every person who joins a clinical trial helps move cancer one step forward.”
To date, he has tolerated therapy remarkably well and with promising results—the cancer is not spreading and the smaller tumor on his lung has reduced in size. “Life is good today,” he says. “I may not be what I used to be but I’m a heck of a lot better than I would have been without the clinical trial.”
Thomas has not lost his trademark positivity and sense of humor. He refers to the nurses and staff at FCS as “God’s little angels on earth here to help us.” “They all know my name and are always cheering us on,” he said.
During his clinic visits he uses his lightheartedness to help put others at ease. Inspired by the way a fellow patient once lifted his late wife’s spirits through laughter, he looks for opportunities to do the same for others. Whether it’s a joke, a story or a shared laugh, he has learned that even small moments of joy can make a difficult day feel a little lighter.
Thomas’ outlook is simple: “No matter what life throws at you, focus on the good, don’t give up and find reasons to smile whenever you can. Every new day is a blessing.”
That spirit has left a lasting impression on those who have been part of his care.
Sherri Cicero, the clinical trial’s research coordinator, said, “Mr. Gray’s resilience and outlook are truly inspiring, and he has a way of bringing positivity to everyone around him! He has made a lasting impression on the team, and we are all grateful for the opportunity to be part of his care.”
“Thomas refuses to let cancer define his story,” says Dr. Vaddepally. “Instead, he chooses to focus on the people he loves, the moments that matter and the opportunity to make a difference for others facing the same disease. Through faith, family, humor and hope, he continues to find happiness every day.”